disoxaril has been researched along with isoxazoles in 46 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (34.78) | 18.7374 |
1990's | 21 (45.65) | 18.2507 |
2000's | 7 (15.22) | 29.6817 |
2010's | 2 (4.35) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chapman, MS; Diana, GD; Dutko, FJ; Kim, KH; Mallamo, JP; Minor, I; Oliveira, M; Pevear, DC; Rossmann, MG | 1 |
Diana, GD; Dutko, FJ; Fox, MP; McKinlay, MA | 1 |
Andries, K; Dewindt, B; Lewi, PJ; Snoeks, J; Stokbroekx, R; Willebrords, R | 1 |
Boeyé, A; Rombaut, B | 1 |
Andries, K; Boeyé, A; Rombaut, B | 1 |
Blaas, D; Diana, GD; Gruenberger, M; Kuechler, E; Pevear, D | 1 |
Almela, MJ; Carrasco, L; González, ME | 1 |
Boeyé, A; Brioen, P; Rombaut, B | 1 |
de Jong, JC | 1 |
Guidinger, PL; Jubelt, B; McKinlay, MA; Ropka, SL; Wilson, AK | 1 |
Badger, J; Dutko, FJ; Fancher, M; Heinz, BA; McKinlay, MA; Rossmann, MG; Rueckert, RR; Shepard, DA; Smith, TJ | 1 |
al-Nakib, W; Andries, K; Dearden, C; Tyrrell, DA; Woestenborghs, R | 1 |
Habermehl, KO; McKinlay, MA; Otto, MJ; Willingmann, P; Zeichhardt, H | 1 |
Diana, GD; Maliski, EG; McKinlay, MA; Oglesby, RC; Otto, MJ; Rossmann, MG; Smith, TJ; Treasurywala, AM | 1 |
Akullian, V; Cutcliffe, D; Diana, GD; Mallamo, JP; McKinlay, MA; Oglesby, RC; Otto, MJ | 1 |
Diana, GD; Fancher, MJ; Fox, MP; Kuhrt, MF; McKinlay, MA; Otto, MJ | 1 |
Akullian, V; Diana, GD; McKinlay, MA; Oglesby, C; Otto, MJ | 1 |
Diana, GD; McKinlay, MA; Otto, MJ | 1 |
Arnold, E; Diana, GD; Kamer, G; Kremer, MJ; Luo, M; McKinlay, MA; Otto, MJ; Rossmann, MG; Smith, TJ; Vriend, G | 1 |
Fox, MP; McKinlay, MA; Otto, MJ | 1 |
Rossmann, MG | 1 |
McKinlay, MA; Steinberg, BA | 1 |
Benziger, DP; Frank, JA; McKinlay, MA; Steinberg, BA | 1 |
McKinlay, MA | 1 |
Andries, K; Dewindt, B; van Eemeren, K | 1 |
Mosser, AG; Rueckert, RR; Sgro, JY | 1 |
Aldous, S; Bailey, TR; Diana, GD; Dutko, FJ; Long, MA; Nitz, TJ; Pevear, DC; Vescio, N; Volkots, DL | 1 |
Didarholm, H; Frisk, G; Halloran, M | 1 |
Boeyé, A; Delaet, I | 1 |
Bailey, TR; Cutcliffe, D; Diana, GD; Giranda, V; Mallamo, JP; Nitz, TJ; Oglesby, RC; Vescio, N; Volkots, DL; Wetzel, J | 1 |
Guha-Biswas, M; Holder, M; Pettitt, BM | 1 |
Mosser, AG; Rueckert, RR | 1 |
Arnold, E; Buontempo, P; Cox, S; De Martino, J; Miller, G; O'Connell, J; Rozhon, E; Schwartz, J; Slater, W; Zhang, A | 1 |
Galabov, AS; Nikolaeva, L | 4 |
Balbi, A; Corrias, S; De Montis, A; Garzoglio, R; Grandi, T; La Colla, P; Mazzei, M | 1 |
Dove, AW; Racaniello, VR | 1 |
Demontis, F; Dondero, R; Ledda, B; Mazzei, M; Vargiu, L | 1 |
Galabov, AS; Nikolova, I | 1 |
Galabov, AS; Nikolaeva-Glomb, L | 1 |
Crowder, S; Kirkegaard, K | 1 |
Giannone, I; Landolfi, C; Milanese, C; Musumeci, T; Paolino, D; Pignatello, R; Puglisi, G; Ragni, L; Ventura, CA | 1 |
Cardosa, J; Kuhn, RJ; Perera, R; Plevka, P; Rossmann, MG; Yap, ML | 1 |
Galabov, AS; Vassileva-Pencheva, R | 1 |
1 review(s) available for disoxaril and isoxazoles
Article | Year |
---|---|
Inhibitors of picornavirus uncoating as antiviral agents.
Topics: Animals; Anti-Infective Agents; Antiviral Agents; Chalcone; Chalcones; Ciprofloxacin; Flavonoids; Fluoroquinolones; Furans; Humans; Isoxazoles; Ketones; Picornaviridae; Picornaviridae Infections; Quinolines; Rhinovirus; Structure-Activity Relationship | 1985 |
45 other study(ies) available for disoxaril and isoxazoles
Article | Year |
---|---|
Conformationally restricted analogues of disoxaril: a comparison of the activity against human rhinovirus types 14 and 1A.
Topics: Antiviral Agents; Binding Sites; Humans; Isoxazoles; Models, Molecular; Rhinovirus; Structure-Activity Relationship | 1992 |
Binding affinities of structurally related human rhinovirus capsid-binding compounds are related to their activities against human rhinovirus type 14.
Topics: Antiviral Agents; Capsid; Cells, Cultured; Dose-Response Relationship, Drug; Half-Life; Humans; Isoxazoles; Kinetics; Microbial Sensitivity Tests; Rhinovirus | 1991 |
A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program.
Topics: Antiviral Agents; Capsid; Drug Design; Drug Evaluation, Preclinical; Isoxazoles; Models, Biological; Rhinovirus; Structure-Activity Relationship | 1991 |
In vitro assembly of poliovirus 14 S subunits: disoxaril stabilization as a model for the antigenicity conferring activity of infected cell extracts.
Topics: Antibodies, Monoclonal; Antigens, Viral; Antiviral Agents; Capsid; Epitopes; HeLa Cells; Humans; Isoxazoles; Kinetics; Poliovirus; Temperature | 1991 |
A comparison of WIN 51711 and R 78206 as stabilizers of poliovirus virions and procapsids.
Topics: Antiviral Agents; Capsid; Epitopes; Half-Life; Isoxazoles; Molecular Structure; Piperidines; Poliovirus; Protein Precursors; Pyridazines; Viral Core Proteins; Virion | 1991 |
Stabilization of human rhinovirus serotype 2 against pH-induced conformational change by antiviral compounds.
Topics: Antiviral Agents; Hydrogen-Ion Concentration; Isoxazoles; Precipitin Tests; Protein Conformation; Rhinovirus; Serotyping; Viral Proteins | 1991 |
Inhibitors of poliovirus uncoating efficiently block the early membrane permeabilization induced by virus particles.
Topics: Antiviral Agents; Cell Membrane; Cell Membrane Permeability; Cells, Cultured; Chalcone; Chalcones; Endoribonucleases; Fungal Proteins; HeLa Cells; Heparin; Humans; Isoxazoles; Phosphatidylcholines; Poliovirus; Protein Synthesis Inhibitors; Virion | 1991 |
Disoxaril stabilization and immunogenicity of poliovirus procapsids.
Topics: Animals; Antibodies, Viral; Antigens, Viral; Capsid; HeLa Cells; Humans; Hydrogen-Ion Concentration; Immunization; Isoxazoles; Mice; Mice, Inbred BALB C; Neutralization Tests; Oxazoles; Poliovirus; Protein Denaturation; Temperature; Virion | 1990 |
[Can anything curative be done against the common cold?].
Topics: Antiviral Agents; Common Cold; Humans; Interferons; Isoxazoles; Rhinovirus; Viral Vaccines | 1986 |
Clearance of a persistent human enterovirus infection of the mouse central nervous system by the antiviral agent disoxaril.
Topics: Animals; Antiviral Agents; Brain; Cyclophosphamide; Disease Models, Animal; Drug Resistance, Microbial; Enterovirus Infections; Immunosuppression Therapy; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Oxazoles; Poliomyelitis; Poliovirus | 1989 |
Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound.
Topics: Antiviral Agents; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HeLa Cells; Humans; Isoxazoles; Models, Molecular; Molecular Conformation; Molecular Structure; Mutation; Oxazoles; Rhinovirus; Viral Plaque Assay | 1989 |
Drug resistant rhinoviruses from the nose of experimentally treated volunteers.
Topics: Antiviral Agents; Chalcone; Drug Resistance, Microbial; Flavonoids; Humans; Isoxazoles; Microbial Sensitivity Tests; Nose; Pyridazines; Rhinovirus | 1989 |
Inhibition of poliovirus uncoating by disoxaril (WIN 51711).
Topics: Antiviral Agents; Capsid; Depression, Chemical; Endocytosis; HeLa Cells; Humans; Isoxazoles; Lysosomes; Oxazoles; Poliovirus; RNA, Viral; Virus Replication | 1987 |
Enantiomeric effects of homologues of disoxaril on the inhibitory activity against human rhinovirus-14.
Topics: Antiviral Agents; Computer Simulation; Humans; Isoxazoles; Models, Molecular; Oxazoles; Rhinovirus; Stereoisomerism; Structure-Activity Relationship; X-Ray Diffraction | 1988 |
Synthesis and structure-activity studies of some disubstituted phenylisoxazoles against human picornavirus.
Topics: Antiviral Agents; Coronaviridae; Humans; Isoxazoles; Oxazoles; Structure-Activity Relationship | 1989 |
In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
Topics: Antiviral Agents; Culture Media; Enterovirus; HeLa Cells; Humans; Isoxazoles; Oxazoles; Picornaviridae; Rhinovirus; Time Factors; Viral Plaque Assay; Virus Replication | 1985 |
[[(4,5-Dihydro-2-oxazolyl)phenoxy]alkyl]isoxazoles. Inhibitors of picornavirus uncoating.
Topics: Animals; Chemical Phenomena; Chemistry; Dose-Response Relationship, Drug; Isoxazoles; Mice; Oxazoles; Picornaviridae Infections; Poliovirus; Rhinovirus; Structure-Activity Relationship; Time Factors; Virus Replication | 1985 |
The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.
Topics: Antiviral Agents; Binding Sites; Chemical Phenomena; Chemistry; Humans; Isoxazoles; Poliovirus; Rhinovirus; X-Ray Diffraction | 1986 |
Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
Topics: Antiviral Agents; Cells, Cultured; Centrifugation, Density Gradient; Hot Temperature; Humans; Isoxazoles; Oxazoles; Poliovirus; Rhinovirus; Sucrose; Time Factors; Uridine; Virus Replication | 1986 |
Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus.
Topics: Antiviral Agents; Capsid; HIV; HIV Core Protein p24; Isoxazoles; Models, Molecular; Picornaviridae; Protein Conformation; Retroviridae Proteins; Structure-Activity Relationship | 1988 |
Oral efficacy of WIN 51711 in mice infected with human poliovirus.
Topics: Animals; Antiviral Agents; Brain; Female; Humans; Isoxazoles; Mice; Mice, Inbred ICR; Oxazoles; Poliomyelitis; Spinal Cord; Time Factors | 1986 |
Use of WIN 51711 to prevent echovirus type 9-induced paralysis in suckling mice.
Topics: Administration, Oral; Animals; Animals, Suckling; Antiviral Agents; Echovirus 9; Echovirus Infections; Injections, Intraperitoneal; Isoxazoles; Mice; Oxazoles; Paralysis; Tissue Distribution | 1986 |
WIN 51711, a new systematically active broad-spectrum antipicornavirus agent.
Topics: Antiviral Agents; Capsid; Isoxazoles; Oxazoles; Picornaviridae; Viral Proteins | 1985 |
Antiviral capsid-binding compounds can inhibit the adsorption of minor receptor rhinoviruses.
Topics: Adsorption; Antiviral Agents; Capsid; Chalcone; Chalcones; Flavonoids; HeLa Cells; Humans; Isoxazoles; Mutation; Protein Conformation; Pyridazines; Receptors, Virus; Rhinovirus | 1994 |
Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions.
Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Capsid; Drug Resistance, Microbial; HeLa Cells; Humans; Isoxazoles; Kinetics; Membrane Proteins; Models, Biological; Models, Molecular; Point Mutation; Poliovirus; Protein Conformation; Protein Structure, Secondary; Receptors, Virus; RNA, Viral; Temperature; Viral Plaque Assay | 1994 |
Oxadiazoles as ester bioisosteric replacements in compounds related to disoxaril. Antirhinovirus activity.
Topics: Antiviral Agents; Esters; HeLa Cells; Humans; Isoxazoles; Oxadiazoles; Rhinovirus | 1994 |
Stabilization of the antigenicity of coxsackie B procapsids by disoxaril.
Topics: Antibodies, Viral; Antigens, Viral; Capsid; Drug Stability; Enterovirus; Enterovirus B, Human; Enterovirus Infections; Humans; Immunoglobulin M; Isoxazoles; Proviruses; Radioimmunoassay; Virology | 1993 |
Capsid destabilization is required for antibody-mediated disruption of poliovirus.
Topics: Antibodies, Monoclonal; Antibodies, Viral; Capsid; Isoxazoles; Neutralization Tests; Osmolar Concentration; Poliovirus; Temperature | 1994 |
Antipicornavirus activity of tetrazole analogues related to disoxaril.
Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Humans; Isoxazoles; Microbial Sensitivity Tests; Molecular Sequence Data; Picornaviridae; Rhinovirus; Structure-Activity Relationship; Tetrazoles | 1993 |
On the mechanism of HRV-14 antiviral compounds: "slow growth" as a conformational search procedure.
Topics: Amino Acid Sequence; Antiviral Agents; Binding Sites; Chemical Phenomena; Chemistry, Physical; Crystallography, X-Ray; Electrochemistry; Hydrogen Bonding; Isoxazoles; Molecular Conformation; Molecular Sequence Data; Molecular Structure | 1993 |
WIN 51711-dependent mutants of poliovirus type 3: evidence that virions decay after release from cells unless drug is present.
Topics: Antiviral Agents; Drug Resistance, Microbial; HeLa Cells; Hot Temperature; Humans; Isoxazoles; Mutagenesis; Poliovirus; Virion; Virus Replication | 1993 |
SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
Topics: Animals; Antiviral Agents; Capsid; Enterovirus B, Human; HeLa Cells; Humans; Imidazoles; Isoxazoles; Male; Mice; Mice, Inbred BALB C; Mice, Inbred ICR; Picornaviridae; Poliovirus; Rhinovirus; Therapeutic Equivalency | 1993 |
Synergistic inhibitory effect of enviroxime and disoxaril on poliovirus type 1 replication.
Topics: Antiviral Agents; Benzimidazoles; Cell Line; Drug Resistance; Drug Synergism; Humans; Isoxazoles; Oximes; Poliovirus; Ribavirin; Sulfonamides; Virus Replication | 1995 |
Synthesis and antirhinovirus activity of 3-(diethylamino)-5-phenylisoxazole derivatives.
Topics: Antiviral Agents; Cytopathogenic Effect, Viral; HeLa Cells; HIV-1; Humans; Isoxazoles; Rhinovirus; Virus Replication | 1996 |
An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Topics: Antiviral Agents; Capsid; HeLa Cells; Humans; Isoxazoles; Poliovirus; Receptors, Virus; Temperature | 2000 |
Cytotoxicity of the synergistic antienteroviral combination of enviroxime and disoxaril.
Topics: Antiviral Agents; Benzimidazoles; Cells, Cultured; Drug Synergism; Humans; Isoxazoles; Oximes; Poliovirus; Sulfonamides; Virus Replication | 1999 |
In vitro inhibitory effects of dual combinations of picornavirus replication inhibitors.
Topics: Antiviral Agents; Benzimidazoles; Cell Line; Drug Combinations; Drug Interactions; Drug Synergism; Guanidine; Humans; Isoxazoles; Ketones; Oximes; Phenylthiourea; Poliovirus; Pyrimidines; Sulfonamides; Virus Replication | 1999 |
Disoxaril-related 3-(diethylamino)-5-phenylisoxazoles.
Topics: Antiviral Agents; HIV-1; Isoxazoles; Rhinovirus; Structure-Activity Relationship | 2000 |
Antiviral effect of the combination of enviroxime and disoxaril on coxsackievirus B1 infection.
Topics: Animals; Antiviral Agents; Benzimidazoles; Cell Line; Coxsackievirus Infections; Drug Synergism; Enterovirus B, Human; Humans; Isoxazoles; Mice; Mice, Inbred ICR; Oximes; Sulfonamides; Virus Replication | 2000 |
Development of resistance to disoxaril in Coxsackie B1 virus-infected newborn mice.
Topics: Animals; Animals, Newborn; Antiviral Agents; Brain; Cell Line; Coxsackievirus Infections; Drug Resistance, Viral; Enterovirus B, Human; Isoxazoles; Mice; Mutation; Phenotype; Temperature; Viral Plaque Assay; Virulence | 2003 |
Synergistic drug combinations against the in vitro replication of Coxsackie B1 virus.
Topics: Antiviral Agents; Benzimidazoles; Cell Line; Drug Combinations; Drug Synergism; Enterovirus B, Human; Humans; Isoxazoles; Ketones; Oximes; Phenylthiourea; Pyrimidines; Sulfonamides; Virus Replication | 2004 |
Trans-dominant inhibition of RNA viral replication can slow growth of drug-resistant viruses.
Topics: Alleles; Antiviral Agents; Capsid Proteins; Cysteine Endopeptidases; Drug Resistance, Viral; Genome, Viral; HeLa Cells; Humans; Isoxazoles; Models, Molecular; Mutation; Phenotype; Poliovirus; Protein Biosynthesis; Viral Proteins; Virus Replication | 2005 |
Physico-chemical characterization of disoxaril-dimethyl-beta-cyclodextrin inclusion complex and in vitro permeation studies.
Topics: Animals; beta-Cyclodextrins; Cattle; Cell Membrane Permeability; Chemistry, Pharmaceutical; Drug Carriers; Drug Stability; Hydrophobic and Hydrophilic Interactions; Isoxazoles; Kinetics; Nasal Mucosa; Rabbits; Solubility; Spectrum Analysis; Thermodynamics; Water | 2006 |
Structure of human enterovirus 71 in complex with a capsid-binding inhibitor.
Topics: Capsid Proteins; Crystallization; Enterovirus A, Human; Flow Cytometry; Humans; Isoxazoles; Models, Molecular; Protein Conformation; Virion; X-Ray Diffraction | 2013 |
Effectiveness of the Consecutive Alternating Administration Course of a Triple Antiviral Combination in Coxsackievirus B3 Infections in Mice.
Topics: Animals; Animals, Newborn; Antiviral Agents; Apomorphine; Coxsackievirus Infections; Drug Therapy, Combination; Enterovirus B, Human; Guanidine; Isoxazoles; Mice; Mice, Inbred ICR | 2016 |